文献速递乳腺技术与安全US

新型CEUS联合BI-RADS评分减少乳腺假阳性活检的单中心研究

Can the new combined CEUS-BI-RADS score (CB score) reduce the number of breast false positive biopsies? Results from a monocentric study.
PubMed 文献 · Radiol Med · 2026-01-22

本研究回顾性纳入289例女性294个新诊断乳腺病灶(BI-RADS 4a-c及5),由两名不同经验读者进行CEUS定性评估并构建CEUS与BI-RADS联合评分(CB score)。结果显示CB score诊断性能优于单纯CEUS评分(平均AUC 0.935 vs 0.890,p<0.0001),可避免最多40%的不必要活检。

要点

  • CB score可提高乳腺病变良恶性分类准确性,平均AUC达0.935。
  • CB score在不同经验读者间一致性好,经验较少读者AUC亦可达0.922。
  • 应用CB score最多可减少40%不必要的超声引导下乳腺活检。

核心结论

  • CEUS联合BI-RADS评分系统(CB score)可提高乳腺癌分类诊断性能,并减少不必要活检比例。
  • CB score在不同经验读者间显示较高准确性和一致性。

研究设计与样本

  • 所有病灶均计划行超声引导下活检并接受CEUS检查;由两名独立读者(高年资乳腺放射科医生>10年经验,低年资培训医生>3年经验)进行CEUS定性评估。
  • 参考标准为超声引导下活检病理结果;采用描述性统计、AUC、ROC分析、敏感度及特异度评估诊断性能。

关键影像表现/征象

  • 两名读者对CEUS进行定性评估,评估内容包括与周围组织相比的增强时间和强度、增强模式及造影后病灶大小增加情况。
  • 149个病灶为恶性,146个病灶为良性;平均病灶大小16.6±13.7 mm。

诊断标准与关键数值

  • CB score诊断性能高于单纯CEUS评分:平均AUC分别为0.935与0.890(p<0.0001);高年资读者AUC为0.947,低年资读者AUC为0.922。
  • CB score可避免最多40%的不必要活检。

临床应用与阅片要点

  • 对BI-RADS 4a-c及5类乳腺病灶,结合CEUS定性特征与BI-RADS分类进行CB score评估,有助于减少假阳性活检。
  • CB score在不同经验水平读者间均具较高诊断性能,提示该评分系统有较好临床应用可推广性。

局限性

  • 本研究为单中心回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to develop a new contrast-enhanced ultrasound (CEUS)-based scoring system to distinguish between benign and malignant lesions and to evaluate its potential in obviating unnecessary ultrasound-guided breast biopsies.

METHODS: Between November 2019 and June 2023, women with newly diagnosed breast lesions (BI-RADS 4a-c and 5) scheduled for ultrasound-guided biopsy and who underwent CEUS were retrospectively included. Two independent readers (one highly experienced breast radiologist with > 10 years of experience in breast imaging and one in training with > 3 years of experience) assessed all CEUS studies qualitatively in terms of time and intensity of enhancement compared with surrounding tissue, enhancement pattern and size increase after contrast administration, assigning a CEUS score. Further, a combined BI-RADS and CEUS score (CB score) was obtained. Descriptive statistics, AUC (area under the curve), receiver operating characteristic (ROC) analysis, sensitivity and specificity were used to investigate the diagnostic performance of this combined approach.

RESULTS: A total of 294 lesions in 289 women (mean age 59.8 years; age range 23-88) were analyzed. The average lesion size was 16.6 ± 13.7 mm. Of these, 149 were malignant and 146 benign. CB score showed the highest diagnostic performance compared to CEUS score alone (average AUC = 0.935 vs. 0.890, respectively; p < 0.0001). For the more experienced reader, CB score yielded an AUC of 0.947; for the less experienced reader, AUC was 0.922. Finally, CB score would have obviated up to 40% of unnecessary biopsies.

CONCLUSION: The combined CEUS and BI-RADS scoring system (CB score) improved diagnostic performance for breast cancer classification and showed high accuracy and consistency across readers with different experience, reducing the rate of unnecessary biopsies.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Portaluri, Trimarchi, Wang, et al. Can the new combined CEUS-BI-RADS score (CB score) reduce the number of breast false positive biopsies? Results from a monocentric study. Radiol Med. 2026. PMID: 41569508. doi:10.1007/s11547-026-02179-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。